×
Home Current Archive Editorial board
News Contact
Research paper

Predictors of potential drug-drug interactions in patients at intensive care unit

By
Ivana Iličković ,
Ivana Iličković
Vesna Orlandić-Čejović ,
Vesna Orlandić-Čejović
Sanja Tanasković ,
Sanja Tanasković
Slobodan Janković Orcid logo
Slobodan Janković

Abstract

References

1.
Rana D, Suthar J, Malhotra S, Patel V, Patel P. A study of potential adverse drug-drug interactions among prescribed drugs in medicine outpatient department of a tertiary care teaching hospital. Journal of Basic and Clinical Pharmacy. 2014;5(2):44.
2.
Reimche L, Forster AJ, van Walraven C. Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients. The Journal of Clinical Pharmacology. 2011;51(7):1043–50.
3.
Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm. 2006;9:427–33.
4.
Li M, Krishna MT, Razaq S, Pillay D. A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ‘penicillin allergy’ in a UK teaching hospital. Journal of Clinical Pathology. 2014;67(12):1088–92.
5.
Pandharipande PP, Patel MB, Barr J. Management of pain, agitation, and delirium in critically ill patients. Polish Archives of Internal Medicine. 2014;124(3):114–23.
6.
Barr J, Kishman CP, Jaeschke R. The Methodological Approach Used to Develop the 2013 Pain, Agitation, and Delirium Clinical Practice Guidelines for Adult ICU Patients. Critical Care Medicine. 2013;41:S1–15.
7.
Back C, Wittmann M, Haen E. Verwirrtheitszustände als wichtige Arzneimittelwirkung. Therapeutische Umschau. 2011;68(1):27–33.
8.
Dechanont S, Maphanta S, Butthum B, Kongkaew C. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta‐analysis. Pharmacoepidemiology and Drug Safety. 2014;23(5):489–97.
9.
Smithburger PL, Kane-Gill SL, Seybert AL. Drug–drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. International Journal of Pharmacy Practice. 2012;20(6):402–8.
10.
GÜLÇEBİ İDRİZ OĞLU M, KÜÇÜKİBRAHİMOĞLU E, KARAALP A, SARIKAYA Ö, DEMIRKAPU M, ONAT F, et al. Potential drug–drug interactions in a medical intensive care unit of a university hospital. TURKISH JOURNAL OF MEDICAL SCIENCES. 2016;46:812–9.
11.
Reis AMM, Cassiani SHDB. Adverse drug events in an intensive care unit of a university hospital. European Journal of Clinical Pharmacology. 2011;67(6):625–32.
12.
Apidi NA, Murugiah MK, Muthuveloo R, Soh YC, Caruso V, Patel R, et al. Mobile Medical Applications for Dosage Recommendation, Drug Adverse Reaction, and Drug Interaction: Review and Comparison. Therapeutic Innovation & Regulatory Science. 2017;51(4):480–5.
13.
Kothari N. Potential Drug - Drug Interactions among Medications Prescribed to Hypertensive Patients. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH.
14.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases. 1987;40(5):373–83.
15.
Rønning M, Salvesen Blix H, Tange Harbø B, Strøm H. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – are drug utilisation data comparable? European Journal of Clinical Pharmacology. 2000;56(9–10):723–7.
16.
Kuscu F, Ulu A, Inal AS, Suntur BM, Aydemir H, Gul S, et al. Potential Drug–Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study. Medical Science Monitor. 24:4240–7.
17.
Hassanzad M, Arenas‐Lopez S, Baniasadi S. Potential Drug–Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center. The Journal of Clinical Pharmacology. 2018;58(2):221–7.
18.
Reis AMM, De Bortoli Cassiani SH. Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil. Clinics. 2011;66(1):9–15.
19.
Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, et al. Risk factors for potential drug-drug interactions in intensive care unit patients. Journal of Critical Care. 2018;43:1–6.
20.
Farcas A, Bucsa C, Sinpetrean A, Leucuta D, Mogosan C, Dumitrascu D, et al. Preventability analysis of adverse drug reactions detected in two internal medicine departments in Romania. Internal and Emergency Medicine. 2014;9(2):187–93.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.